Introduction: The remaining barriers to normalcy in cystic fibrosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1099-0496|50|S40|S1-S2

ISSN： 8755-6863

Source： PEDIATRIC PULMONOLOGY, Vol.50, Iss.S40, 2015-10, pp. : S1-S2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

News & Views in ... Cystic Fibrosis

By  

Therapy, Vol. 8, Iss. 6, 2011-11 ,pp. : 597-599

Future Medicine

Access to resources Recommend Favorite

Ceramide in cystic fibrosis

By Ziobro Regan M   Henry Brian D   Lentsch Alex B   Edwards Michael J   Riethmüller Joachim   Gulbins Erich  

Clinical Lipidology, Vol. 8, Iss. 6, 2013-12 ,pp. : 681-692

Future Medicine

Access to resources Recommend Favorite

Targeting Inflammation in Cystic Fibrosis

By  

Respiration, Vol. 79, Iss. 3, 2009-12 ,pp. : 189-190

Karger

Access to resources Recommend Favorite

Cystic Fibrosis in Focus

By  

Respiration, Vol. 67, Iss. 1, 2000-02 ,pp. : 2-2

Karger

Access to resources Recommend Favorite

Genotype and Phenotype in Cystic Fibrosis

By  

Respiration, Vol. 67, Iss. 2, 2000-04 ,pp. : 117-133

Karger

Access to resources Recommend Favorite